The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
Before founding his own company, he held various positions as business editor, fund advisor, portfolio manager and finally as CEO of a listed investment company. He also held several positions on the supervisory board.
He is passionate about analyzing a wide variety of business models and investigating new trends, especially in the areas of e-commerce, fintech, blockchain or artificial intelligence.
Commented by Stefan Feulner
Commented by Stefan Feulner on August 5th, 2021 | 11:26 CEST
NIO, AdTiger, Alibaba - Opportunity China
To ensure data security, cross-border data flow and management of confidential information of Chinese companies whose shares are traded abroad, tech companies, in particular, came into the focus of Chinese regulators. A sell-off followed the uncertainty in related stocks. Companies such as Baidu, Tencent or Alibaba lost disproportionately and offer attractive long-term entry opportunities at the corrected level.
Read
Commented by Stefan Feulner on August 4th, 2021 | 12:21 CEST
Evotec, Barsele Minerals, Nikola - When will the starting signal follow?
It has become quiet on the gold market. After the emerging fears of possible interest rate hikes due to rising inflation, the precious yellow metal remains in the range of around USD 1,800 per ounce. The price should be significantly higher due to the continued ultra-loose monetary policy of the central banks and the highs in government debt. Given that a slowdown in bond purchases or even larger interest rate hikes is hardly possible, a rise in the gold price can barely be avoided in the long term. The opportunity for an anticyclical entry is still given.
Read
Commented by Stefan Feulner on August 4th, 2021 | 11:54 CEST
BMW, NSJ Gold, Infineon - Enormous demand
In recent months, the shortage of semiconductors has been a major headache for the manufacturing sector, especially for carmakers. Production losses and short-time work were the result of the global shortage. There seems to be no improvement in sight. Leading chip manufacturer Intel expects the chip shortage to worsen in the coming months and does not expect the situation to ease for at least two years. There is a similar shortage of raw materials for the energy transition. Position yourself in good time.
Read
Commented by Stefan Feulner on August 3rd, 2021 | 13:12 CEST
Amazon, Aspermont, Zoom - Economies of scale without end
The reporting season is in full swing. While e-commerce giant Amazon disappointed both investors and analysts with a weak outlook, Apple and Tesla came up with better than expected numbers. Unnoticed by the mainstream, a publishing company is evolving into a media technology company with unlimited scaling potential. Be there from the start to profit from the next Amazon.
Read
Commented by Stefan Feulner on August 3rd, 2021 | 12:22 CEST
Siemens Healthineers, Cardiol Therapeutics, BioNTech - Tomorrow's blockbusters
The fight against the coronavirus and the possible return to everyday life promises companies in the biotechnology sector billions in profits. At the forefront, vaccine producers such as BioNTech with its pharmaceutical partner Pfizer or Moderna are the primary beneficiaries of the pandemic. In addition, start-ups are emerging from the diagnostics and therapy sectors, whose formulations have blockbuster potential and could follow a similar path to the vaccine manufacturers in the coming years.
Read
Commented by Stefan Feulner on August 2nd, 2021 | 12:27 CEST
Linde, dynaCERT, Nikola - Profiting from change
With the amended Climate Protection Act, the targets for lower CO² emissions have been raised once again by the German government. Germany is to achieve greenhouse gas neutrality by 2045, and even negative emissions are targeted after 2050. To achieve this, an emergency program worth EUR 8 billion has been launched. The program aims to accelerate the decarbonization of the economy, climate-friendly mobility, and green hydrogen production, among other things. Benefit from the energy transition!
Read
Commented by Stefan Feulner on July 30th, 2021 | 13:28 CEST
Aixtron, Defense Metals, Nordex - Strong growth
The global economic recovery and rising investment in more climate-friendly energy infrastructure are driving higher commodity prices amid supply chain disruptions. Shortages of industrial metals, which are urgently needed for climate change, are likely to materialize further in the coming years. The swelling trade conflict between the USA and China will exacerbate this significantly. There is a threat of massive bottlenecks in production and sharply rising prices for the respective materials.
Read
Commented by Stefan Feulner on July 29th, 2021 | 11:08 CEST
JinkoSolar, Carnavale Resources, BASF - Beware of shortages!
The change from fossil fuels to renewable energy sources due to climate change means that raw materials such as copper, lithium and nickel are increasingly in demand. The increasing demand due to new economic sectors such as wind power, electromobility or photovoltaics is offset by an extremely scarce supply. The result is sharply rising prices and an expected shortage in the coming years. In addition, the trade conflict with China is visibly worsening the shortage. The primary beneficiaries of this dilemma are commodity producers who can at least partially cover the supply deficit outside the Middle Kingdom.
Read
Commented by Stefan Feulner on July 28th, 2021 | 13:42 CEST
Commerzbank, Aztec Minerals, MorphoSys - Save yourself!
The fear of rapidly rising interest rates was taken away from investors at the past meetings of the central banks. In addition to the ECB's change in monetary policy strategy, where the inflation target of "below or close to 2%" was set aside, the Federal Reserve is blithely continuing its money printing. Despite a 5.4% increase in prices in June, US monetary watchdogs continue to focus on a growing economy and a robust labor market and continue to hold off on a monetary policy response. These hesitant measures put financial stability at risk - the best conditions for investment in precious metals.
Read
Commented by Stefan Feulner on July 27th, 2021 | 13:01 CEST
BioNTech, XPhyto Therapeutics, MorphoSys - Here we go again
The numbers of new SARS-CoV-2 infections in Germany are rising again, albeit still at a relatively low level. Due to the spread of the Delta variant, Health Minister Jens Spahn warns of incidences beyond the 800 mark as early as this fall. In addition to masking and spacing, the issues surrounding vaccines against the various mutations and regular, reliable testing are returning to the front pages of the news pages.
Read